FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155055839> ?p ?o ?g. }

• W2155055839 endingPage "1096" @default.
• W2155055839 startingPage "1089" @default.
• W2155055839 abstract "Objective:An antidepressant’s tolerability, generally captured as the frequency and severity of adverse events (AEs), is often as important as its efficacy in determining treatment success. This study used a composite outcome – remission of major depressive disorder (MDD) without AEs – to compare the benefit–risk profiles of escitalopram versus the norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine extended release (XR).Methods:Pooled data from three randomized, double-blind, multicenter trials were analyzed, in which patients with MDD were treated for 8 weeks with either escitalopram (n = 462) or an SNRI (n = 467).Clinical trial registration: clinicaltrials.gov identifiers: NCT00108979; NCT00384436.Main outcome measures:The composite outcome was defined as remission (Montgomery–Åsberg Depression Rating Scale [MADRS] score ≤10) and concurrent absence of an AE. The proportions of remitted patients free of (1) any AEs, (2) moderate-to-severe AEs, and (3) study drug–related AEs were compared between treatment groups at each study visit and longitudinally across study visits common to all trials during the first 8 weeks of treatment.Results:At endpoint (week 8), escitalopram-treated patients were more likely than SNRI-treated patients to experience remission free of any AEs (28.4 vs. 21.6%; p = 0.0179) and remission free of study drug–related AEs (45.2 vs. 36.8%; p = 0.0092). Compared to SNRI-treated patients, escitalopram-treated patients had 38% greater odds of remission free of any AEs, 28% greater odds of remission free of moderate-to-severe AEs, and 34% greater odds of remission free of study drug–related AEs (all p < 0.05).Conclusion:Treatment of adult MDD patients with escitalopram was significantly more likely to result in remission without concurrent AEs compared to treatment with current SNRIs. Study limitations include focus on only the initial 8 weeks of treatment and exclusion of trials for which individual patient data were not obtained." @default.
• W2155055839 created "2016-06-24" @default.
• W2155055839 creator A5004009842 @default.
• W2155055839 creator A5008711263 @default.
• W2155055839 creator A5021395991 @default.
• W2155055839 creator A5038879980 @default.
• W2155055839 creator A5039428639 @default.
• W2155055839 creator A5075220171 @default.
• W2155055839 creator A5089194015 @default.
• W2155055839 date "2011-03-28" @default.
• W2155055839 modified "2023-09-22" @default.
• W2155055839 title "Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors" @default.
• W2155055839 cites W1539382539 @default.
• W2155055839 cites W154379355 @default.
• W2155055839 cites W1583327662 @default.
• W2155055839 cites W185721752 @default.
• W2155055839 cites W1867335213 @default.
• W2155055839 cites W1889727824 @default.
• W2155055839 cites W1965337629 @default.
• W2155055839 cites W1971393265 @default.
• W2155055839 cites W1975870015 @default.
• W2155055839 cites W1982721912 @default.
• W2155055839 cites W1985280182 @default.
• W2155055839 cites W1994418303 @default.
• W2155055839 cites W1996105921 @default.
• W2155055839 cites W2003363634 @default.
• W2155055839 cites W2011003051 @default.
• W2155055839 cites W2011390619 @default.
• W2155055839 cites W2017585287 @default.
• W2155055839 cites W2018008180 @default.
• W2155055839 cites W2019024524 @default.
• W2155055839 cites W2037481801 @default.
• W2155055839 cites W2037824539 @default.
• W2155055839 cites W2047902057 @default.
• W2155055839 cites W2051675429 @default.
• W2155055839 cites W2056648954 @default.
• W2155055839 cites W2061862339 @default.
• W2155055839 cites W2062251052 @default.
• W2155055839 cites W2068083208 @default.
• W2155055839 cites W2069090735 @default.
• W2155055839 cites W2077534611 @default.
• W2155055839 cites W2083225519 @default.
• W2155055839 cites W2087564554 @default.
• W2155055839 cites W2110862289 @default.
• W2155055839 cites W2114613490 @default.
• W2155055839 cites W2122251694 @default.
• W2155055839 cites W2131823335 @default.
• W2155055839 cites W2132577167 @default.
• W2155055839 cites W2137296158 @default.
• W2155055839 cites W2140746866 @default.
• W2155055839 cites W2141398558 @default.
• W2155055839 cites W2149154629 @default.
• W2155055839 cites W2153939786 @default.
• W2155055839 cites W2165973903 @default.
• W2155055839 cites W2038130137 @default.
• W2155055839 doi "https://doi.org/10.1185/03007995.2011.567255" @default.
• W2155055839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21438794" @default.
• W2155055839 hasPublicationYear "2011" @default.
• W2155055839 type Work @default.
• W2155055839 sameAs 2155055839 @default.
• W2155055839 citedByCount "9" @default.
• W2155055839 countsByYear W21550558392012 @default.
• W2155055839 countsByYear W21550558392013 @default.
• W2155055839 countsByYear W21550558392014 @default.
• W2155055839 countsByYear W21550558392015 @default.
• W2155055839 countsByYear W21550558392016 @default.
• W2155055839 countsByYear W21550558392019 @default.
• W2155055839 countsByYear W21550558392021 @default.
• W2155055839 crossrefType "journal-article" @default.
• W2155055839 hasAuthorship W2155055839A5004009842 @default.
• W2155055839 hasAuthorship W2155055839A5008711263 @default.
• W2155055839 hasAuthorship W2155055839A5021395991 @default.
• W2155055839 hasAuthorship W2155055839A5038879980 @default.
• W2155055839 hasAuthorship W2155055839A5039428639 @default.
• W2155055839 hasAuthorship W2155055839A5075220171 @default.
• W2155055839 hasAuthorship W2155055839A5089194015 @default.
• W2155055839 hasConcept C118552586 @default.
• W2155055839 hasConcept C126322002 @default.
• W2155055839 hasConcept C142724271 @default.
• W2155055839 hasConcept C156957248 @default.
• W2155055839 hasConcept C197934379 @default.
• W2155055839 hasConcept C204787440 @default.
• W2155055839 hasConcept C2776466888 @default.
• W2155055839 hasConcept C2778375690 @default.
• W2155055839 hasConcept C2779144063 @default.
• W2155055839 hasConcept C2779177272 @default.
• W2155055839 hasConcept C2779583969 @default.
• W2155055839 hasConcept C2780051608 @default.
• W2155055839 hasConcept C2780764818 @default.
• W2155055839 hasConcept C2781161787 @default.
• W2155055839 hasConcept C31487548 @default.
• W2155055839 hasConcept C71924100 @default.
• W2155055839 hasConceptScore W2155055839C118552586 @default.
• W2155055839 hasConceptScore W2155055839C126322002 @default.
• W2155055839 hasConceptScore W2155055839C142724271 @default.
• W2155055839 hasConceptScore W2155055839C156957248 @default.
• W2155055839 hasConceptScore W2155055839C197934379 @default.
• W2155055839 hasConceptScore W2155055839C204787440 @default.

• next